Jefferies is reiterating its Buy rating on shares of Metabolix (NASDAQ: MBLX), but is lowering its price target from $19 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE